ZIMV - ZimVie Announces Definitive Agreement to Sell Spine Business to H.I.G. Capital for $375 Million | Benzinga
Proposed Sale Establishes a Pure-Play Dental Company with a Leading Implant Portfolio
Net Proceeds Will be Used to Pay Down Debt and Support Dental Growth Initiatives
WESTMINSTER, Colo., Dec. 18, 2023 (GLOBE NEWSWIRE) -- ZimVie Inc. (NASDAQ:ZIMV), a global life sciences leader in the dental and spine markets, today announced it has entered into a definitive agreement to sell its spine business to H.I.G. Capital, a leading global alternative investment firm.
ZimVie intends to utilize the after-tax proceeds to reduce debt, consistent with the company's stated capital allocation priorities. The deal is expected to be accretive to ZimVie's revenue growth rate, EBITDA margin, and cash flow conversion rate by allowing the company to streamline operations and sharpen its focus as a well-positioned, pure-play dental company in higher-growth end markets.
"We are pleased to reach an agreement with H.I.G. Capital for the strategic sale of our core spine, motion preservation, and EBI® Bone Healing portfolio and services. Our spine business possesses an innovative portfolio, and is well positioned to continue to improve under this new ownership. Similarly, this transaction provides the capital to fund go-forward growth for dental's commercial and innovation platforms while reducing ZimVie's leverage profile," said Vafa Jamali, President and CEO. "This transaction is intended to create a leaner, more focused ZimVie with a leading position in attractive and growing global dental markets."
"We would also like to thank all of our employees globally. Our teams have made tremendous contributions to transforming and improving our business profile, and these actions continue today," Mr. Jamali added.
"The ZimVie spine business has a solid foundation with a market-leading product portfolio, strong surgeon satisfaction and exceptional patient outcomes," said Mike Gallagher, Managing Director at H.I.G. Capital. "We see a tremendous opportunity to partner with the spine leadership team to support best-in-class innovation and robust commercial execution. The combination of H.I.G.'s expertise in the medical device space and the capabilities of ZimVie spine management will create an innovation engine for distributors, surgeons and patients."
Terms of the Agreement
Under the terms of the agreement, upon the closing of the transaction, ZimVie will receive $375 million in total consideration, comprised of $315 million in cash, subject to certain customary adjustments as set forth in the agreement, and $60 million in the form of a ...